How Much Upside is Left in Altimmune (ALT)? Wall Street Analysts Think 285.86%

Core Viewpoint - Altimmune, Inc. (ALT) shares have increased by 39.4% in the past four weeks, closing at $5.80, with a mean price target of $22.38 indicating a potential upside of 285.9% [1] Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $5.32, where the lowest estimate of $12 suggests a 106.9% increase, and the highest estimate of $28 indicates a potential surge of 382.8% [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about ALT's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 2.3% over the past month, with one estimate increasing and no negative revisions [12] - ALT holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13]